Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17062351rdf:typepubmed:Citationlld:pubmed
pubmed-article:17062351lifeskim:mentionsumls-concept:C0007600lld:lifeskim
pubmed-article:17062351lifeskim:mentionsumls-concept:C1512505lld:lifeskim
pubmed-article:17062351lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:17062351lifeskim:mentionsumls-concept:C1514485lld:lifeskim
pubmed-article:17062351lifeskim:mentionsumls-concept:C0338204lld:lifeskim
pubmed-article:17062351pubmed:issue10lld:pubmed
pubmed-article:17062351pubmed:dateCreated2006-10-25lld:pubmed
pubmed-article:17062351pubmed:abstractTextTo investigate the inhibitory effects of (188)Re-labeled herceptin on the proliferation in vitro of breast carcinoma cell line (SKBR-3) overexpressing HER-2/neu proto-oncogene.lld:pubmed
pubmed-article:17062351pubmed:languagechilld:pubmed
pubmed-article:17062351pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17062351pubmed:citationSubsetIMlld:pubmed
pubmed-article:17062351pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17062351pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17062351pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17062351pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17062351pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17062351pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17062351pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17062351pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17062351pubmed:statusMEDLINElld:pubmed
pubmed-article:17062351pubmed:monthOctlld:pubmed
pubmed-article:17062351pubmed:issn1673-4254lld:pubmed
pubmed-article:17062351pubmed:authorpubmed-author:LiGui-pingGPlld:pubmed
pubmed-article:17062351pubmed:authorpubmed-author:ZhangYi-fanYFlld:pubmed
pubmed-article:17062351pubmed:authorpubmed-author:WangYong-xian...lld:pubmed
pubmed-article:17062351pubmed:issnTypePrintlld:pubmed
pubmed-article:17062351pubmed:volume26lld:pubmed
pubmed-article:17062351pubmed:ownerNLMlld:pubmed
pubmed-article:17062351pubmed:authorsCompleteYlld:pubmed
pubmed-article:17062351pubmed:pagination1455-7lld:pubmed
pubmed-article:17062351pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:17062351pubmed:meshHeadingpubmed-meshheading:17062351...lld:pubmed
pubmed-article:17062351pubmed:meshHeadingpubmed-meshheading:17062351...lld:pubmed
pubmed-article:17062351pubmed:meshHeadingpubmed-meshheading:17062351...lld:pubmed
pubmed-article:17062351pubmed:meshHeadingpubmed-meshheading:17062351...lld:pubmed
pubmed-article:17062351pubmed:meshHeadingpubmed-meshheading:17062351...lld:pubmed
pubmed-article:17062351pubmed:meshHeadingpubmed-meshheading:17062351...lld:pubmed
pubmed-article:17062351pubmed:meshHeadingpubmed-meshheading:17062351...lld:pubmed
pubmed-article:17062351pubmed:meshHeadingpubmed-meshheading:17062351...lld:pubmed
pubmed-article:17062351pubmed:meshHeadingpubmed-meshheading:17062351...lld:pubmed
pubmed-article:17062351pubmed:meshHeadingpubmed-meshheading:17062351...lld:pubmed
pubmed-article:17062351pubmed:meshHeadingpubmed-meshheading:17062351...lld:pubmed
pubmed-article:17062351pubmed:year2006lld:pubmed
pubmed-article:17062351pubmed:articleTitle[188Re-labeled herceptin inhibits proliferation of breast cancer cell line SKBR-3 in vitro].lld:pubmed
pubmed-article:17062351pubmed:affiliationDepartmant of Nuclear Medicine, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China. ligp@fimmu.comlld:pubmed
pubmed-article:17062351pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17062351pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:17062351pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed